Drug Giant Pfizer to Build $100 Million R&D Center in Boston
06/13/2011
The new world headquarters for the Centers for Therapeutic Innovation will house 40 employees and Pfizer's drug-development activity, and complement the company's existing offices in Cambridge.
Work at the facility will be done in collaboration with various renowned Boston-based medical and research centers. They include: the University of Massachusetts Medical School, Tufts Medical School, Beth Israel Deaconess Medical Center, Children's Hospital Boston, Partners Healthcare, Harvard University, Boston University and Tufts University. Pfizer indicated in a press release these partners could earn "milestone payments" for successful development of the "next generation of medicines."
"These partnerships allow leading medical and clinical experts to join with Pfizer's highly-skilled scientists and advanced drug development capabilities to speed the translation of innovative science into medicines for patients," said Jose Carlos Gutierrez-Ramos, Ph.D., senior VP and head of BioTherapeutics Research and Development for Pfizer. "Our ultimate goal is to bridge the gap between scientific discovery and the delivery of promising candidates to the pipeline."
Project Announcements
Ireland-Based Linde Plans Brownsville, Texas, Operations
06/12/2025
Canadian-Based Torvan Medical Plans High Point, North Carolina, Headquarters-Production Operations
06/12/2025
Amazon Web Services Plans Richmond County, North Carolina, Operations
06/12/2025
Rolls-Royce Expands Mankato, Minnesota, Manufacturing Operations
06/12/2025
StandardAero Component Services Expands Sharonville, Ohio, MRO Operations
06/12/2025
Azure Farms Plans South Point, Ohio, Production Operations
06/12/2025
Most Read
-
First Person: Joe Capes, CEO, LiquidStack
Q2 2025
-
The Legal Limits of DEI in Incentives Agreements, Hiring, and Contracting
Q2 2025
-
39th Annual Corporate & 21st Annual Consultants Surveys: What Business Leaders and Consultants Are Saying About Site Selection
Q1 2025
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
Why Cold Storage May Defy the Tariff Crunch
Q2 2025
-
Get Your Mega Site ‘Project Ready’
Q2 2025
-
Navigating the new era of SCIF construction
Q1 2025